Ada Francia

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Episodic Ataxia Type 2 (EA2) and Spinocerebellar Ataxia Type 6 (SCA6) Due to CAG Repeat Expansion in the CACNA1A Gene on Chromosome 19p

Carla Jodice, Elide Mantuano, Liana Veneziano et al. · Human Molecular Genetics · 1997 · 291 citations · Full text

Chromosome 19P, Cacna1a Gene, Mendelian Disorder +14

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

Eduardo Nobile‐Orazio, Dario Cocito, S. Jann et al. · The Lancet Neurology · 2012 · 213 citations

Autoimmune Disease, Scleroderma, Chronic Inflammatory +8

Neuropsychiatric lupus syndromes

Antonella Afeltra, Pierluigi Garzia, Anna Paola Mitterhofer et al. · Neurology · 2003 · 148 citations

Neuropsychology, Neuropsychiatric Disorders, Neuropsychiatric Manifestations +19

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)

G. Sabbadini, Ada Francia, L. Calandriello et al. · Brain · 1995 · 123 citations

Genetics, Genetic Epidemiology, Recurrent Stroke Episodes +20